Nanomaterials as Novel Cardiovascular Theranostics.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiology

Background:

• Cardiovascular diseases (CVDs) are the primary global cause of mortality.
• Conventional diagnostics and therapeutics for CVDs have limitations.
• Nanotheranostics integrate diagnosis and therapy using nanoparticles.

Purpose of the Study:

• To review the evolution and application of nano-based theranostics for CVDs.
• To highlight the potential of nanotheranostics in managing atherosclerosis, myocardial infarction, and angiogenesis.
• To explore future directions for nanotherapeutics in cardiovascular medicine.

Main Methods:

• Literature review on nano-based theranostics for cardiovascular diseases.
• Analysis of engineered nanoparticles' properties for diagnosis and therapy.
• Discussion of current and emerging nanotherapeutic strategies.

Main Results:

• Engineered nanoparticles offer unique physicochemical properties for CVD management.
• Nano-based theranostics show potential in early detection and treatment of atherosclerosis and myocardial infarction.
• Nanotheranostics are emerging as a powerful tool for cardiovascular disease management.

Conclusions:

• Nano-based theranostics represent a significant advancement over conventional methods for CVDs.
• Nanotherapeutics hold promise for transforming cardiovascular diagnostics and therapeutics.
• Further research into nanotheranostics is crucial for improving patient outcomes in CVDs.